1 completed, 1 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
Follow Tumor Infiltrating Lymphocytes: new trials by email Literature Review of Tumor Infiltrating Lymphocytes trials Research Report on Tumor Infiltrating Lymphocytes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of GC101 TIL in Advanced Melanoma (BZ) GC101 TIL - Tumor Infiltrating Lymphocytes, Safety | Phase 1 / Phase 2 | Completed | Shanghai Juncell Therapeutics | 18 | 2023-11-08 | 2025-12-23 |
| Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer Autologous tumor-infiltrating lymphocytes - Tumor Infiltrating Lymphocytes | Phase 1 / Phase 2 | Not yet recruiting | Women's Hospital School Of Medicine Zhejiang University | 91 | 2022-01-01 | 2021-12-10 |
Drug-Related Side Effects and Adverse Reactions (1) · Melanoma (1)
Chemically-Induced Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1) · Neuroendocrine Tumors (1) · Nevi and Melanomas (1) · Skin Diseases (1) · Skin Neoplasms (1) · Skin and Connective Tissue Diseases (1)
Shanghai Juncell Therapeutics (1) · Women's Hospital School Of Medicine Zhejiang University (1)
China (1)
Hui Wang, MD (1) · Jun Guo (1)